BSECompany Update2d ago · 5 Oct 2026, 05:03 pm
As per attachment.
Vipul Organics Ltd · 530627
✦ AI SummaryM&A
Vipul Organics Ltd has informed about the alteration of the Object Clause of the Memorandum of Association, amendment to the Employee Stock Option Scheme, and re-appointment of the Managing Director.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vipul Organics Ltd - 530627 - Disclosure Under Regulation 30 Read With Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Attachments (1)
📄pdf
Download →
7cef827e-0e07-4fb0-96a2-64eb219b2574.pdf
View document text
05th October 2026
The Manager
Department of Corporate Services
BSE Limited, Phiroze Jeejeebhoy Towers,
Dalal Street, Fort, Mumbai 400001
Scrip code: 530627
Sub.: Disclosure under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015.
Dear Sir/Ma’am,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations,
2015, and read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 as amended
from time to time (SEBI Master Circular).
This is to inform that in furtherance to our letter dated August 14, 2026 and based on the report of the
Scrutinizer, the shareholders at the 54th Annual General Meeting ("AGM") held on Wednesday,
September 30, 2026, have approved the following resolutions.
1. Alteration of the Object Clause of the Memorandum of Association of the Company by expanding the
scope of the existing Main Object through addition of the proposed additional objects under Clause
III(A)(1), without altering or deleting the existing objects contained therein. The details of the proposed
alteration are enclosed herewith as Annexure A.
2. Amendment to the “Vipul Organics Limited – Employee Stock Option Scheme, 2022” (“VOL ESOS 2022”),
by amending Clause 8.1(a) relating to the Exercise Period. The details of the proposed amendment are
enclosed herewith as Annexure B.
3. The Board approved the re-appointment of Mr. Vipul P. Shah (DIN: 00181636) as the Managing Director
of the Company for a period of 5 (five) years with effect from June 15, 2027 up to June 14, 2032. The
details as required under Regulation 30 of the Listing Regulations are enclosed herewith as Annexure C.
The details & disclosure as required under SEBI LODR read with SEBI Master Circular No.
HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated 30th January 2026 is given and enclosed herewith.
Yours faithfully,
For Vipul Organics Limited
Vipul Shah
Managing Director
DIN: 00181636
Encl.: As above
Details under Regulation 30 of the SEBI Listing Regulations read along with SEBI Circular No.
SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Annexure-A
Particulars Brief Alteration
Alteration of the Object Clause of the Memorandum of Association of the
Company by expanding the scope of the existing Main Object under Clause
Alteration in
III(A)(1), by insertion of additional objects, without altering or deleting the
1. Memorandum of
existing object contained therein, as approved by the Members of the Company
Association (MOA)
by way of Special Resolution at the 54th Annual General Meeting and such
other approvals, permissions and sanctions as may be required.
The existing Main Object under Clause III(A)(1)
To carry on the business of manufacture, process, purchase, resale, export,
import and commission agency of all types of Laboratory fine and heavy
Existing Object
chemicals whether organic or inorganic and including dyes acid and
intermediates and minerals and to refine, purify derivate, crystallise, process,
dry and to carry out such other process or processes, activity or activities to
carry out this object.
To carry on the business of designers, developers, manufacturers, fabricators,
assemblers, processors, buyers, sellers, importers, exporters, suppliers,
distributors, installers, maintainers, and service providers of all types and
generations of membrane products, membrane components, membrane
modules, and integrated membrane separation systems. This includes, but is
not limited to, Ultrafiltration (UF), Microfiltration (MF), Nanofiltration (NF),
Reverse Osmosis (RO), Forward Osmosis (FO), Membrane Bioreactors (MBR),
Electrodialysis (ED/EDR), Gas Separation Membranes, and specialized
polymeric, ceramic, or metallic membranes for industrial, commercial,
municipal, and domestic applications.
Proposed Additional
To engage in the business of engineering, procurement, construction,
Objects
commissioning, operation, and maintenance of water treatment plants,
wastewater treatment facilities, water recycling, and environmental
engineering systems. This encompasses Sewage Treatment Plants (STP),
Effluent Treatment Plants (ETP), Common Effluent Treatment Plants (CETP),
Zero Liquid Discharge (ZLD) systems, Desalination plants, water recycling, and
resource recovery systems, along with all associated civil, mechanical,
electrical, and instrumentation works.
To conceptualize, design, manufacture, and supply specialized separation,
purification, concentration, and recovery systems for industrial process fluids,
liquids, gases, and air. This includes applications in pharmaceuticals,
Particulars Brief Alteration
biotechnology, food and beverage, chemical processing, petrochemicals, oil
and gas, power generation, and the capture, purification, or separation of
industrial gases like hydrogen, nitrogen, carbon dioxide, and biogas.
To manufacture, trade, lease, rent, import, and export all types of ancillary
equipment, machinery, and components required for water treatment, water
management, fluid handling and separation systems. This includes high-
pressure pumps, pressure vessels, housings, valves, piping, chemical dosing
systems, control panels, SCADA and automation software, filtration media,
chemicals, antiscalants, cleaning reagents, and analytical testing instruments”.
The proposed alteration is intended to enable the Company to diversify and
expand its business operations and to undertake business opportunities in the
Reason for
areas of membrane technology, water and wastewater treatment,
Alteration
environmental engineering, separation and purification systems and allied
equipment and components.
The proposed alteration is approved by the Members of the Company by way
Approval
of Special Resolution at the 54th Annual General Meeting .
Annexure-B
Particulars Details
Vipul Organics Limited – Employee Stock Option Scheme, 2022 (“VOL –
1. Name of the Scheme
ESOS 2022”)
Brief details of option Not applicable (this disclosure pertains to amendment of the Scheme
granted and not to grant of Options).
Whether the scheme is
3. in terms of SEBI (SBEB & Yes
SE) Regulations, 2021
Total number of shares
4. covered under these 2,00,000 (Two Lakh) Equity Shares of Rs. 10/- each
options
Not applicable (this disclosure pertains to amendment of the Scheme
5. Pricing formula
and not to vesting of Options).
Not applicable (this disclosure pertains to amendment of the Scheme
6. Options vested
and not to vesting of Options).
Existing: The exercise period shall be decided by the Compensation
Committee from time to time and shall not be longer than 3 months
Time within which
7. from the date of vesting.
option may be exercised
Proposed: The exercise period shall be decided by the Compensation
Committee from time to time and shall not be longer than 2 years from
Particulars Details
the date of vesting. The Options will lapse if not exercised within the
specified exercise period, subject to the terms of the Scheme.
Not applicable (this disclosure pertains to amendment of the Scheme
8. Option exercised
and not to exercise of Options).
Money realized by Not applicable (this disclosure pertains to amendment of the Scheme
exercise of options and not to exercise of Options).
Total number of shares
Not applicable (this disclosure pertains to amendment of the Scheme
10. arising as a result of
and not to exercise of Options).
exercise of option
Not applicable (this disclosure pertains to amendment of the Scheme
11. Options lapsed
and not to lapse of Options).
Amendment of Clause 8.1(a) –
Exercise Period: Existing Provision:
a. The exercise period shall be decided by the Compensation Committee
from time to time, save as otherwise provided here-in-under, which shall
not be longer than a period of 3 months from the date of vesting. The
Options will lapse if not exercised within the specified exercise period.
The Options may also lapse under certain circumstances as may be
determined by the Compensation Commit
[Showing first 8,000 characters — download PDF for full document]